GlassScriptPhysician profile
Melissa J Thomas
NPI 1558751453
$3,031.63
in general payments reported to CMS, 2019-2025
36 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $293 · 2022: $769 · 2023: $639 · 2024: $770 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946 · Education: $24.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.20 |
| Education | $24.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $630.84 | 2021-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $404.51 | 2021-2025 | |
| Lilly USA, LLC | $343.13 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $138.74 | 2023-2025 | Tepezza, Repatha, Evenity |
| Novartis Pharmaceuticals Corporation | $113.07 | 2022-2025 | |
| Corcept Therapeutics | $109.80 | 2023-2025 | Korlym |
| Radius Health, INC. | $109.39 | 2023-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $107.35 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Medtronic, INC. | $87.73 | 2023-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $82.03 | 2023-2024 | |
| Dexcom, INC. | $81.11 | 2023-2024 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $70.73 | 2022-2023 | Strensiq |
| Astrazeneca Pharmaceuticals LP | $67.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.22 | 2021-2025 | Jardiance |
| Abbott Laboratories | $55.92 | 2023-2025 | Freestyle Libre 3 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.